349 related articles for article (PubMed ID: 31676012)
1. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
Silkenstedt E; Arenas F; Colom-Sanmartí B; Xargay-Torrent S; Higashi M; Giró A; Rodriguez V; Fuentes P; Aulitzky WE; van der Kuip H; Beà S; Toribio ML; Campo E; López-Guerra M; Colomer D
J Exp Clin Cancer Res; 2019 Nov; 38(1):446. PubMed ID: 31676012
[TBL] [Abstract][Full Text] [Related]
2. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
López-Guerra M; Xargay-Torrent S; Fuentes P; Roldán J; González-Farré B; Rosich L; Silkenstedt E; García-León MJ; Lee-Vergés E; Giménez N; Giró A; Aymerich M; Villamor N; Delgado J; López-Guillermo A; Puente XS; Campo E; Toribio ML; Colomer D
Oncogene; 2020 Feb; 39(6):1185-1197. PubMed ID: 31616059
[TBL] [Abstract][Full Text] [Related]
3. Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis.
Mancarella S; Serino G; Dituri F; Cigliano A; Ribback S; Wang J; Chen X; Calvisi DF; Giannelli G
Cell Death Differ; 2020 Aug; 27(8):2330-2343. PubMed ID: 32042099
[TBL] [Abstract][Full Text] [Related]
4. Dll4/Notch1 signalling pathway is required in collective invasion of salivary adenoid cystic carcinoma.
Wang K; Fan HY; Pang X; Zhang M; Yu XH; Wu JS; Chen BJ; Jiang J; Liang XH; Tang YL
Oncol Rep; 2021 Mar; 45(3):1011-1022. PubMed ID: 33469672
[TBL] [Abstract][Full Text] [Related]
5. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.
Kridel R; Meissner B; Rogic S; Boyle M; Telenius A; Woolcock B; Gunawardana J; Jenkins CE; Cochrane C; Ben-Neriah S; Tan K; Morin RD; Opat S; Sehn LH; Connors JM; Marra MA; Weng AP; Steidl C; Gascoyne RD
Blood; 2012 Mar; 119(9):1963-71. PubMed ID: 22210878
[TBL] [Abstract][Full Text] [Related]
6. Targeted Notch1 inhibition with a Notch1 antibody, OMP-A2G1, decreases tumor growth in two murine models of prostate cancer in association with differing patterns of DNA damage response gene expression.
Ahmed AA; Robinson T; Palande M; Escara-Wilke J; Dai J; Keller ET
J Cell Biochem; 2019 Oct; 120(10):16946-16955. PubMed ID: 31099068
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma.
Xargay-Torrent S; López-Guerra M; Montraveta A; Saborit-Villarroya I; Rosich L; Navarro A; Pérez-Galán P; Roué G; Campo E; Colomer D
Clin Cancer Res; 2013 Feb; 19(3):586-97. PubMed ID: 23231952
[TBL] [Abstract][Full Text] [Related]
8. Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway.
Zhang Y; Zhang Y; Wang J; Gu H
Biomed Res Int; 2020; 2020():5391058. PubMed ID: 33145353
[TBL] [Abstract][Full Text] [Related]
9. A novel peptide inhibitor of Dll4-Notch1 signalling and its pro-angiogenic functions.
Zhu G; Lin Y; Ge T; Singh S; Liu H; Fan L; Wang S; Rhen J; Jiang D; Lyu Y; Yin Y; Li X; Benoit DSW; Li W; Xu Y; Pang J
Br J Pharmacol; 2022 Apr; 179(8):1716-1731. PubMed ID: 34796471
[TBL] [Abstract][Full Text] [Related]
10. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1.
Pedrosa AR; Trindade A; Fernandes AC; Carvalho C; Gigante J; Tavares AT; Diéguez-Hurtado R; Yagita H; Adams RH; Duarte A
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1134-46. PubMed ID: 25767274
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth.
Ding XY; Ding J; Wu K; Wen W; Liu C; Yan HX; Chen C; Wang S; Tang H; Gao CK; Guo LN; Cao D; Li Z; Feng GS; Wang HY; Xu ZF
Oncogene; 2012 Jun; 31(23):2899-906. PubMed ID: 22002304
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors.
Aste-Amézaga M; Zhang N; Lineberger JE; Arnold BA; Toner TJ; Gu M; Huang L; Vitelli S; Vo KT; Haytko P; Zhao JZ; Baleydier F; L'Heureux S; Wang H; Gordon WR; Thoryk E; Andrawes MB; Tiyanont K; Stegmaier K; Roti G; Ross KN; Franlin LL; Wang H; Wang F; Chastain M; Bett AJ; Audoly LP; Aster JC; Blacklow SC; Huber HE
PLoS One; 2010 Feb; 5(2):e9094. PubMed ID: 20161710
[TBL] [Abstract][Full Text] [Related]
13. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
[TBL] [Abstract][Full Text] [Related]
14. DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activation.
Miao ZF; Xu H; Xu HM; Wang ZN; Zhao TT; Song YX; Xu YY
Cancer Med; 2017 Jan; 6(1):245-257. PubMed ID: 27891816
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of δ-like ligand 4 and Notch1 in acute myeloid leukemia.
Zhang J; Ma D; Ye J; Zang S; Lu F; Yang M; Qu X; Sun X; Ji C
Oncol Rep; 2012 Oct; 28(4):1503-11. PubMed ID: 22858860
[TBL] [Abstract][Full Text] [Related]
16. In vivo growth of mantle cell lymphoma xenografts in immunodeficient mice is positively regulated by VEGF and associated with significant up-regulation of CD31/PECAM1.
Molinský J; Klánová M; Maswabi B; Soukup T; Trněný M; Nečas E; Živný J; Klener P
Folia Biol (Praha); 2013; 59(1):26-31. PubMed ID: 23537525
[TBL] [Abstract][Full Text] [Related]
17. [Effect of silencing NOTCH1 gene by shRNA interference on AKT/mTOR pathway in mantle cell lymphoma].
Huang YQ; Huang XL; Ma XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1616-20. PubMed ID: 25543484
[TBL] [Abstract][Full Text] [Related]
18. NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications.
Deshotels L; Safa FM; Saba NS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373427
[TBL] [Abstract][Full Text] [Related]
19. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway.
Sun HW; Wu C; Tan HY; Wang QS
Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.
Marchesini M; Gherli A; Montanaro A; Patrizi L; Sorrentino C; Pagliaro L; Rompietti C; Kitara S; Heit S; Olesen CE; Møller JV; Savi M; Bocchi L; Vilella R; Rizzi F; Baglione M; Rastelli G; Loiacono C; La Starza R; Mecucci C; Stegmaier K; Aversa F; Stilli D; Lund Winther AM; Sportoletti P; Bublitz M; Dalby-Brown W; Roti G
Cell Chem Biol; 2020 Jun; 27(6):678-697.e13. PubMed ID: 32386594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]